Equator Therapeutics
San Francisco
About Equator Therapeutics
Equator Therapeutics develops a drug that burns calories and improves metabolism. It offers a drug that can solve obesity and type 2 diabetes problem because it addresses the root cause of metabolic disorders. Its drug will target mitochondria, the powerhouse of the cell. It will activate the protein that mitochondria naturally use to produce heat. The company's approach has been proven to reverse obesity and type 2 diabetes in animals. It has developed a high-throughput drug discovery platform to identify compounds that selectively activate its target protein, without side effects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $650.0K
- Last round: Series Unknown (Jan 2022)
- Website: equatortherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/equator-therapeutics-2266 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.